Success Stories: We Supported a Postdoctoral Fellow in the Field of Biochemistry to Secure NIW Approval, No RFE Issuance

Posted by wegreened on January 17, 2022 in NIW, Chemistry (Organic Chemistry, Biochemistry, Biochemical Engineering, Electrochemical Engineering, Physical Chemistry, Macromolecular Engineering, Polymer Chemistry, Chemical Engineering)

Client’s Testimonial:

“I am delighted with the excellent service I received for my NIW petition from North America Immigration Law Group. They did a prompt and detailed initial review of my case before accepting it. During the preparation step, they were very thorough, detailed and provided excellent suggestions showing their immense expertise in these cases. All my questions were answered to satisfaction within 24 hrs most of the time. Their drafting service was also very excellent. Overall, a very positive experience. I will surely recommend them to others.”

On May 27^th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: India

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: May 27^th, 2021

Processing Time: 10 months, 6 days

Case Summary:

A postdoctoral fellow based in New Jersey, possessing a Ph.D. in regulatory biology hired the expert services of North America Immigration Law Group to help him in filing an EB-2 NIW (National Interest Waiver) petition on his behalf. Our client was certain that we would help him in the best possible ways to get him closer to achieving his green card. Thus, we evaluated his exceptional credentials, proving the worth of his experiments to the United States. We highlighted the significance of his education and research benefiting the United States in his petition packet by adding the following relevant information:

Firstly, we detailed his research on eukaryote-specific regions of the eukaryotic ribosome. Specifically, he will study protein synthesis regulation and quality control pathways with the goal of characterizing the mechanisms of ribosomal function. We concluded that his research is crucial to the United States because it facilitates the development of improved antifungal drugs by providing necessary insight regarding the ribosomal region ES7 and its role as a target for antifungal therapies. Fungal infections impact more than 300 million people worldwide.
Also, we noted the 8 peer-reviewed journal articles (4 of them first-authored) published by him in no fewer than 3 highly ranked peer-reviewed journals, which accumulated 55 citations. Moreover, he has been invited to conduct peer reviews for noteworthy journals in the field, and he completed 10 peer reviews to date. As further evidence of his credentials, he has been selected for peer review service by top-tier journals in the field of biochemistry. He had also served as an editor for Biomedicines whereas service as an editor is restricted to professionals who exhibit superior acumen in and familiarity with the subject matter of a field. As such, his selection for this imperative task reflects how highly his opinion and judgment are esteemed by other researchers working in the field of biochemistry.
His work was supported by funding from the Human Frontier Science Program (HFSP), the National Institutes of Health (NIH), and the New Jersey Health Foundation (NJHF). Receiving funding grants from these institutions is dedicated to advancing knowledge on complex living systems and further demonstrating the significance and national importance of our client’s research and his success in the field.

His fellow experts in the field also contributed more insight into the merit of his project, verifying how his unique research background propelled him to the forefront of the field. Given his long-standing record as a leader in the field of biochemistry, it is evident that he will continue to contribute high-quality work that benefits the United States. Therefore, we included five recommendation letters in his EB-2 NIW petition packet whereas one of the recommenders highlighted:

“[Client] has provided important insights into the functional significance of the eukaryote- specific N-terminal extension of rpS5, which plays important role in the development and progression of bone disorders… His research is not only important for scientists working in the biochemistry discipline, but also for the public at large, given that more than 1.5 million osteoporotic fractures occur in the U.S. each year, resulting in over 18$ billion in costs to U.S. citizens. Such numbers indicate that his research is financially significant and relevant to public health in the U.S.”

Successfully, we convinced the USCIS that our client’s intended research is in the best interests of the United States to actively support him to continue, and his NIW petition got approved without raising any further request for evidence (RFE). We sincerely thank him for contacting our law firm and congratulate him for achieving this milestone and becoming a part of this victorious story.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%